A Randomized, Double Blind, Placebo Controlled Evaluation of Modafinil vs Placebo for the Treatment of General Anesthesia Related Delayed Emergence in Patients With the Diagnosis of Obstructive Sleep Apnea

Trial Profile

A Randomized, Double Blind, Placebo Controlled Evaluation of Modafinil vs Placebo for the Treatment of General Anesthesia Related Delayed Emergence in Patients With the Diagnosis of Obstructive Sleep Apnea

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Modafinil (Primary)
  • Indications Hypersomnia
  • Focus Therapeutic Use
  • Acronyms ModOSA
  • Most Recent Events

    • 22 Sep 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
    • 22 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
    • 25 Feb 2016 Planned End Date changed from 1 Aug 2017 to 1 Oct 2017, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top